Pharmacokinetics and Pharmacodynamics of Cumulative Single Doses of Inhaled Salbutamol Enantiomers in Asthmatic Subjects
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 12 (6) , 353-362
- https://doi.org/10.1006/pupt.1999.0217
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Characteristics of indirect pharmacodynamic models and applications to clinical drug responsesBritish Journal of Clinical Pharmacology, 1998
- Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.Thorax, 1997
- Pharmacokinetics of inhaled drugsBritish Journal of Clinical Pharmacology, 1996
- Enantioselective disposition of salbutamol in man following oral and intravenous administrationBritish Journal of Clinical Pharmacology, 1996
- Systemic effects of salbutamol and salmeterol in patients with asthma.Thorax, 1994
- Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").Thorax, 1994
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Active enantiomers may cause adverse effects in asthmaTrends in Pharmacological Sciences, 1992
- Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adultsThe Journal of Pediatrics, 1987
- The mechanism of salbutamol‐induced hypokalaemia.British Journal of Clinical Pharmacology, 1987